Age Group

More options for age range



Showing 1 - 5 of 224 results
Page 1 of 45   


Principal Investigator: Jennifer Robinson, MD, MPH

Department:CPH/Dept. of Epidemiology

The Preventive Intervention Center at the University of Iowa is conducting a study to find out if a new test can predict who may develop cognitive problems due to Alzheimer's disease based on their genes. This research will also test an investigational medication to see if it can delay the symptoms of cognitive disorders.

Adults aged 65-83 may qualify to participate in this study.

Eligible participants receive at no cost:

Memory and thinking evaluations

Laboratory evaluations


Study medication

You may receive compensation for time and travel. The study will last about 5 years and include 5 clinic visits the first year, then 2 visits a year until the end of the study.

To learn more, email us at cph-cognitivehealth@uiowa.edu or call 319/353-8233 or 1-800/887-6917.

age group:65 to 83 years trial start date:January 10, 2014
Gender Preference:none Trial End Date: July 10, 2014
Contact Info:

Study Coordinator: Erin Balkenende 319-353-8233 (erin-balkenende@uiowa.edu)

Principal Investigator: 319-384-5030 (jennifer-g-robinson@uiowa.edu)

Keywords: aging ; Alzheimer ; cognitive health ; dementia ; memory ; older adults ; seniors

Central Sensitization and Individual Differences

Principal Investigator:Laura Frey Law

Department:Physical Therapy & Rehabilitation Science

Healthy volunteers ages 18 to 55, with no serious medical conditions or current pain, are invited to participate in a study involving temporary muscle soreness from an infusion of a slightly acidic or normal saline solution. Visits also include questionnaires, collecting a saliva sample, and sensations of pressure, heat or cold water on the arm. There will be three visits: approximately 1.5 hours/visit.

Compensation available. 

age group:18 to 55 years trial start date:April 2, 2014
Gender Preference:none Trial End Date: January 23, 2015
Contact Info:

Contact Jackie Loesche at 319-335-9795 or email jacquelyn-loesche@uiowa.edu

Keywords: central sensitization ; Enter keyword ; experimental muscle soreness ; pain perception ; personality traits

Caffeine and Motor Memory

Principal Investigator: Kelly Cole, PhD

Department:Health and Human Physiology

We are currently recruiting healthy participants who consume less than 500mg of caffeine per week for a research study that examines the effect of caffeine on motor memory. If you choose to participate, you will be assigned to one of two groups: one group will receive a caffeine pill after learning a new motor skill, and another group will receive a placebo pill after learning a new motor skill. All subjects will visit the laboratory for two consecutive days, for 30-60 minutes each day. During these sessions, you will complete a fine motor task repeatedly.  If interested, please contact Sara at sara-hussain@uiowa.edu

age group:18 to 30 years trial start date:April 14, 2014
Gender Preference:none Trial End Date: October 14, 2014
Contact Info:

Sara at sara-hussain@uiowa.edu

Keywords: caffeine ; dexterity ; memory ; motor learning


Principal Investigator:Sif Hansdottir, MD

Department:Department or Field of Study

Aspire A Postmarketing Observational Study to Assess Respiratory Tract Adverse Events in Pulmonary Arterial Hypertension Patients Treated With Tyvaso®(Treprostinil) Inhalation Solution 

Primary Outcome Measures: Describe the type and incidence of oro-/nasopharyngeal and pulmonary adverse events that may be associated with current or recent treatment with Tyvaso for PAH and with patients not treated with Tyvaso for PAH.

Please refer to www.clinicaltrials.gov for more information identifier NCT01266265

age group:1 to 99 years trial start date:April 11, 2011
Gender Preference:none Trial End Date: January 21, 2015
Contact Info:

Pulmonary Hypertension Program

Cynthia Larew RN 319-356-1028  pager # 2123


Keywords: Enter keyword ; Heart ; inhaled prostacyclin ; observational study ; PAH ; Pulmonary Arterial Hypertension ; pulmonary hypertension ; treprostinil sodium ; Tyvaso

TAH-t Post Markey Surveillance Study

Principal Investigator: Jennifer Goerbig-Campbell, MD

Department:Department or Field of Study

The purpose of this study is to demonstrate that the results achieved in the original pivotal clinical investigation of 81 subjects from five clinical sites are generalizable to new clinical sites that complete the staff training defined in the SynCardia Systems, Inc. Training Manual and who enroll subjects who meet the intended use defined in the product Instructions for Use.


Please refer to www.clinicaltrials.gov identifier NCT00614510 for more information.

age group:18 to 99 years trial start date:August 1, 2006
Gender Preference:none Trial End Date: January 31, 2015
Contact Info:

Cardiomyopathy Treatment Program

Page Scovel, RN

phone:  319-356-1028

fax: 319-356-7087

email: page-scovel@uiowa.edu

Keywords: Artificial heart ; cardiac disease ; Cardiomyopathy ; CHF ; Congestive heart failure ; Heart ; heart disease ; Heart failure ; Mechanical circulatory support
Page 1 of 45
« 1 2 3 4 5  ... » 
Results per page
5 | 15 | 25

Clinical Research Studies

Filter By Started within
Show trials started in last 1 month
Your Selections

We'd welcome your feedback!

Please help us improve your experience on our website by completing a brief survey

Yes, I'll give feedback No, Thanks